Recent

% | $
Quotes you view appear here for quick access.

Pacific Ethanol, Inc. Message Board

jrdelane 414 posts  |  Last Activity: Jun 24, 2016 9:19 AM Member since: Dec 5, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    BJ's response to the trial timeline in Japan.

    by quicktwosmile Jun 23, 2016 9:42 AM
    jrdelane jrdelane Jun 24, 2016 9:19 AM Flag

    You and I both, but I am out now, having exited 2.01 to 2.04. I think Gil and Hardy convinced each other they could get earlier approval, then it started changing, they extended trial to be more robust, 4-5 sites, 150-200 patients, and now we have nearly two years to hear results. I can't bear the wait, look what's happened to the stock since Monday at 2.19. Today it will trade in the mid to low 1.80's. Shorts have this one in their grip, I won't suffer that kind of market risk. I bought precious metals yesterday, am up on that idea 10% already. Good luck, honestly, I believed, like Jason Kolbert said at the R&D Partnership Day, and I accumulated too early, too fast. Now the facts have changed.

  • Reply to

    Rough day ahead

    by trader.12157 Jun 24, 2016 2:33 AM
    jrdelane jrdelane Jun 24, 2016 9:10 AM Flag

    Yes, likely, in 2018. There's a lot of risk between then and now, might as well stay out of this for another year and take my chances on buying lower. Looks what's happened to this stock even since Monday, my point exactly.

  • How will shares here respond? Dry powder may be all important Friday, or Monday?

  • Reply to

    Pondering latest developments?

    by gibis Jun 22, 2016 1:34 PM
    jrdelane jrdelane Jun 23, 2016 12:33 AM Flag

    Thanks for your post, hope to see you again. I've had a rough month and am taking leave of biotech stocks for a time.

  • Reply to

    Pondering latest developments?

    by gibis Jun 22, 2016 1:34 PM
    jrdelane jrdelane Jun 22, 2016 4:41 PM Flag

    I must admit was very upset to see this stock behaving poorly and as pinstripe's posts surfaced on annual meeting, with mention of data readout in Q1 2018, that's where I had a disconnect between what Gil and Hardy had been saying in their R&D Partnership day video, and subsequent interviews and so forth. They clearly were overselling the Japan PMDA program's fast track aspects. As a result, I lost some serious money here, believing in them. One should come to the table with at least two years for any such investment, so I built too large of a position too fast with average price of 2.28 and chose not to risk the fluctuation which was only beginning. I sold at 2.01-2.04 and won't be trusting Gil and Company anymore.

  • Reply to

    Pondering latest developments?

    by gibis Jun 22, 2016 1:34 PM
    jrdelane jrdelane Jun 22, 2016 2:08 PM Flag

    I bought shares based on what was being sold to us as a very fast track pivotal trial and now we know what that looks like when they come back around the corner. When I look at the break in the charts and the delays out front, I sold all my shares for a loss because I know how this trades given time to bleed. Feels like betrayal to me.

  • Reply to

    Ok. So where are the catalysts?

    by gibis Jun 21, 2016 3:48 PM
    jrdelane jrdelane Jun 22, 2016 10:47 AM Flag

    We lost all the upside of the recent move, completely retraced to support area around 2.15. The charts look a bit oversold now though, and I see some sector strength coming in today with the XBI and IBB, we may benefit from a rally there. We've seen 2.19 already this morning only to be smacked right back down by the short cabal, or people who've decided they won't wait and are taking leave.

  • Reply to

    ANNUAL MEETING

    by pinstripe68 Jun 21, 2016 10:15 AM
    jrdelane jrdelane Jun 21, 2016 11:37 PM Flag

    ojsmyth75, I agree there is more risk (chance for error) in having more facilities and med techs, but the longer study also gives the patients more time to recover their function to the point of excellent outcome, per Gil 'completely normal or minor hints of a deficit" as stated in his interview with Jason Kolbert (at the Alliance for Regen Medicine) in March.

  • Reply to

    Venture Capital Firm

    by cinci_shucumber Jun 21, 2016 7:50 PM
    jrdelane jrdelane Jun 21, 2016 10:49 PM Flag

    Athersys's Senior Vice Pres Finance just picked up 57,674 shares - June 21, 2016
    Athersys's Exec Vice Pres and CSO just picked up 131,593 shares - June 21, 2016
    Athersys's President and COO just picked up 114,097 shares - June 21, 2016
    Athersys's Chairman and CEO just picked up 202,253 shares - June 21, 2016
    Athersys director was just granted 30,000 options - June 21, 2016

  • Reply to

    Marinus Addressable Market

    by techsmeck Jun 14, 2016 3:17 PM
    jrdelane jrdelane Jun 21, 2016 10:18 PM Flag

    They had better report your positive results soon or we will have to bounce from even lower levels. This has gotten really ugly, my regrets to all who came here.

  • Reply to

    ANNUAL MEETING

    by pinstripe68 Jun 21, 2016 10:15 AM
    jrdelane jrdelane Jun 21, 2016 5:33 PM Flag

    The larger trial actually reduces the risk as I recall Gil stating, they were in agreement for this reason, when Healios was wanting to go larger.

  • Reply to

    ANNUAL MEETING

    by pinstripe68 Jun 21, 2016 10:15 AM
    jrdelane jrdelane Jun 21, 2016 10:48 AM Flag

    "Results may not be reported until early 2018" but I would imagine they might report based on the 90-day interim results, if deemed important. Remember, Hardy said PMDA would approve based on "safety and a "tendency" of effectiveness". There is the chance that patients responding early to treatment (in sufficient numbers) may be enough for them to approve early. Others here agree or disagree? We have the other trials ongoing, we can't languish until 2018.

  • Reply to

    Teva Walks.......................

    by quicktwosmile Jun 13, 2016 6:37 PM
    jrdelane jrdelane Jun 14, 2016 6:05 PM Flag

    What is it about your posting that attracts so many red thumbs? You are an optimist and maybe people think you pump too much. Shorts don't care what we post, maybe I'm wrong?

  • Reply to

    Latest Healios KK Stock price

    by jrdelane May 22, 2016 11:20 PM
    jrdelane jrdelane Jun 14, 2016 5:57 PM Flag

    2166 for June 14 (14.67%) I wonder if this was in response to Teva dropping Meso CHF partnership. Meso was off 40%, ATHX off 2% or $0.05.

    Sentiment: Strong Buy

  • Reply to

    Focal Onset Conference Call

    by techsmeck Jun 13, 2016 3:34 PM
    jrdelane jrdelane Jun 14, 2016 5:45 PM Flag

    I'm well beyond the point of "just the return of my investment" and I'd go home happy. Not adding just holding and also went back to work. Very tough market, this (if I were to sell now) would be my highest percentage loss ever. I had three chances to take 15% gains and yet it was fleeting each time. We all saw those chances. Biospec smartly took his exit.

    Sentiment: Hold

  • Reply to

    Focal Onset Conference Call

    by techsmeck Jun 13, 2016 3:34 PM
    jrdelane jrdelane Jun 14, 2016 1:55 PM Flag

    The irony is GALE is holding above $2.00 and everybody here was dumping on the risk holding GALE when the greater risk was holding MRNS. I settled for a nice profit on GALE and sadly am holding a 75% loss here. 2016 was the year of the biotech implosion.

  • Reply to

    Nomura Holdings (Japan) just boght 100k more shares

    by unemonl Jun 13, 2016 11:38 AM
    jrdelane jrdelane Jun 13, 2016 6:48 PM Flag

    Healios up again today 0.43%.

    Sentiment: Strong Buy

  • Reply to

    Nevada Lawsuit

    by rneuro26 Jun 9, 2016 2:48 PM
    jrdelane jrdelane Jun 11, 2016 12:26 AM Flag

    A verdict in favor of Decn would be sealed and the Company would finance their expansion into world markets without diluting shareholders. Letting the cash go back to shareholders would be stupid, small cap bios struggle to have enough operating funds to attain profitability. This would be the windfall money bridging them to sustained profitability. Go KB, whack those SOB's!

  • Reply to

    FRX results

    by prospern23 Jun 10, 2016 10:02 PM
    jrdelane jrdelane Jun 10, 2016 11:41 PM Flag

    Very difficult to know what to think, about any of these biotech stocks this year, very tough being right so far, and even then with enough shares to compensate the losses. I went back to work to get away from this action, which amounts to spending time either side of my basis with no real growth.

  • Reply to

    I am amazed ...

    by market_ace Jun 7, 2016 10:35 AM
    jrdelane jrdelane Jun 9, 2016 11:38 AM Flag

    Let's say that people didn't put faith in what Gil says anymore, now though there is the confirmatory phase 2 at one year data, the ratification of the science by the Healios partnership, and you look at what Healios is doing, and whether or not you can trust in Hardy and his leadership,where they are going with Athersys. The story has grown beyond Gil at this point.

PEIX
5.15-0.25(-4.63%)Jun 24 4:00 PMEDT